Research Exchanges

This is Part 1 in a three-part series on key factors in CRO selection. (Check out Part 2 and Part 3). Alternative strategies for approaching drug...

Dr. Kevin Lustig talks about strategic outsourcing and bringing pharma and drug discovery into the information age in an article he recently wrote...

Amidst the many challenges facing the life sciences industry today such as diminishing funding sources, increased costs to develop new drugs and...

This is Part 3 in a three-part series on patient-centered outcomes. (Check out Part 1 and Part 2). Patient perspective (patient-centered outcomes...

This is Part 2 in a three-part series on patient-centered outcomes. (Check out Part 1 and Part 3). A personalized medicine approach to clinical...

This is Part 1 in a three-part series on patient-centered outcomes. (Check out Part 2 and Part 3). In different regulatory and research settings...

Targeted based drug discovery has been a mainstay of pharmaceutical pipelines for the last 20 years. Identifying and validating novel drug...

Scientist announced this morning, the launch of MXIS (Market Exchange for Innovative Services), a virtual outsourcing platform for Pfizer...

Cloud-based Platform Brings Together Life Science Researchers Worldwide; Fuels Innovation at NCI “The mission of CCR is to conduct cutting-edge...

At Scientist, we feel strongly about promoting Open Science and have sponsored a fantastic show on Mendelspod today: an interview with Dr Ethan...